Explores cannabidiol's effects on local anesthesia, indicating it may enhance lidocaine's effectiveness.
BACKGROUND: Cannabidiol (CBD) inhibits voltage-gated sodium channels (Na v ). CBD is highly lipophilic and exhibits slow binding kinetics on Na v s, a property that may enable CBD to enhance and prolong regional anesthesia. Here we explored the effects of CBD on lidocaine-induced Na v -inhibition and neurotoxicity. METHODS: Patch clamp recordings were performed on tetrodotoxin (TTX)-sensitive Na v s and the TTX-resistant Na v 1.8 in ND7/23 cells or murine dorsal root ganglion neurons (DRG). Cytotoxicity was analyzed using flow cytometry. RESULTS: CBD induced a potent tonic inhibition of sodium currents with slow onset and offset kinetics. Na v 1.8 exhibited a higher sensitivity to tonic block (IC 50 1.4 µM) as compared to TTX-sensitive sodium channels (IC 50 2.9 µM). Similar to local anesthetics, CBD also induced a shift of the steady-state inactivation and a modest use-dependent block at 10 Hz. In contrast to local anesthetics, inhibition of Na v s by CBD is pH-independent. The co-application of CBD and lidocaine resulted in an additive tonic block of sodium currents in ND7/23 cells, but not in DRG neurons. While only high concentrations of CBD induced cytotoxicity, it potentiated lidocaine-induced cytotoxicity. CONCLUSIONS: CBD demonstrates promising characteristics as a long-lasting local anesthetic, or as an adjunct to local anesthetics used for regional or topical anesthesia.
No takes yet. Share an insight, caveat, or question.
Stein et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: